Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BHMT | Q93088 | 1/20 | 0.55 |
| ▸ | BHMT2 | Q9H2M3 | 1/20 | 0.55 |
| ▸ | SLC1A3 | P43003 | 3/20 | 0.54 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.54 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.54 |
| ▸ | GABRP | O00591 | 2/20 | 0.54 |
| ▸ | GABRD | O14764 | 2/20 | 0.54 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.54 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.54 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.54 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.54 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.54 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.54 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.54 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.54 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.54 |
| ▸ | GABRE | P78334 | 2/20 | 0.54 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.54 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.54 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13269874 | 1.00 | BHMT (0.55) | BHMTBHMT2SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL17039475 | 1.00 | BHMT (0.55) | BHMTBHMT2SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL1895927 | 1.00 | BHMT (0.55) | BHMTBHMT2SLC1A3SLC1A2SLC1A1 | |
| Hydrochloric Acid SCHEMBL3219774 | 0.97 | BHMT (0.53) | BHMTBHMT2SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL8068164 | 0.86 | GSR (0.68) | BHMTBHMT2SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL602426 | 0.86 | GSR (0.68) | BHMTBHMT2SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL4435999 | 0.85 | GSR (0.58) | SLC1A3SLC1A2SLC1A1GABRPGABRD | |
| SCHEMBL433668 | 0.85 | GSR (0.58) | SLC1A3SLC1A2SLC1A1GABRPGABRD | |
| SCHEMBL16577962 | 0.85 | GSR (0.64) | SLC1A3SLC1A2SLC1A1GABRPGABRD | |
| SCHEMBL17281360 | 0.85 | GSR (0.58) | SLC1A3SLC1A2SLC1A1GABRPGABRD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090036576-A1 | Cyanophycin Production From Nitrogen-Containing Chemicals Obtained From Biomass | ELBAHLOUL YASSER ABDEL KADER | 2009-02-05 | — | — | US | claimed |
| EP-1859047-A1 | CYANOPHYCIN PRODUCTION FROM NITROGEN-CONTAINING CHEMICALS OBTAINED FROM BIOMASS | Wageningen Universiteit (NL) | 2007-11-28 | — | — | EP | claimed |
| US-7270771-B2 | Triazinylaminostilbene disulphonic acid mixtures | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2007-09-18 | — | — | US | claimed |
| WO-2006093411-A1 | CYANOPHYCIN PRODUCTION FROM NITROGEN-CONTAINING CHEMICALS OBTAINED FROM BIOMASS | WAGENINGEN UNIVERSITY (NL) | 2006-09-08 | — | — | WO | claimed |
| US-20260014282-A1 | METHODS OF FORMING RADIOPAQUE PEPTIDES FOR USE IN MEDICAL HYDROGELS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-01-15 | — | — | US | disclosed |
| US-20250361531-A1 | MICROORGANISMS AND METHODS FOR PRODUCTION OF 4-HYDROXYBUTYRATE, 1,4-BUTANEDIOL AND RELATED COMPOUNDS | AGAIN BIO APS (DK) | 2025-11-27 | — | — | US | disclosed |
| US-12312627-B2 | Microorganisms and methods for production of 4-hydroxybutyrate, 1,4-butanediol and related compounds | GENOMATICA, INC. (US) | 2025-05-27 | — | — | US | disclosed |
| EP-4414451-A2 | MICROORGANISMS AND METHODS FOR PRODUCTION OF 4 HYDROXYBUTYRATE, 1,4-BUTANEDIOL AND RELATED COMPOUNDS | Genomatica, Inc. (US) | 2024-08-14 | — | — | EP | disclosed |
| EP-2989113-B1 | MICROORGANISMS AND METHODS FOR PRODUCTION OF 4-HYDROXYBUTYRATE, 1,4-BUTANEDIOL AND RELATED COMPOUNDS | GENOMATICA INC (US) | 2024-04-10 | — | — | EP | disclosed |
| US-11932845-B2 | Microorganisms and methods for production of 4-hydroxybutyrate, 1,4-butanediol and related compounds | GENOMATICA, INC. (US) | 2024-03-19 | — | — | US | disclosed |
| US-20230233592-A1 | PHARMACEUTICAL COMPOSITION FOR THE CHEMICAL INHIBITION OF TGS1 IN THE THERAPEUTIC TREATMENT OF TELOMEROPATHIES | UNIVERSITÀ DEGLI STUDI DI ROMA "LA SAPIENZA" (IT) | 2023-07-27 | — | — | US | disclosed |
| US-20230065295-A1 | MICROORGANISMS AND METHODS FOR PRODUCTION OF 4-HYDROXYBUTYRATE, 1,4-BUTANEDIOL AND RELATED COMPOUNDS | GENOMATICA INC (US) | 2023-03-02 | — | — | US | disclosed |
| EP-0832937-B1 | Water-soluble perylene dyes, their preparation and use | CLARIANT GMBH (DE) | 2000-12-06 | — | — | EP | disclosed |
| EP-0827985-B1 | Water soluble copper phthalocyanine dyes, their manufacture and their use | CLARIANT GMBH (DE) | 2000-11-22 | — | — | EP | disclosed |
| EP-1036822-A1 | Water-soluble red acid dyes, their preparation and use | Clariant GmbH (DE) | 2000-09-20 | — | — | EP | disclosed |
| EP-1036823-A1 | Red acid dyes for ink-jet printing and for colouring paper | Clariant GmbH (DE) | 2000-09-20 | — | — | EP | disclosed |
| US-5948910-A | Water-soluble perylene dyestuffs, their preparation and their use | CLARIANT GMBH (DE) | 1999-09-07 | — | — | US | disclosed |
| US-5882360-A | FOR DYEING AND PRINTING NATURAL AND SYNTHETIC FIBERS; REACTING PHTHALOCYANINE SULFOCHLORIDE WITH AMINOALKYLENECARBOXYLIC ACID | CLARIANT GMBH (DE) | 1999-03-16 | — | — | US | disclosed |
| EP-0832937-A1 | Water-soluble perylene dyes, their preparation and use | Clariant GmbH (DE) | 1998-04-01 | — | — | EP | disclosed |
| EP-0827985-A1 | Water soluble copper phthalocyanine dyes, their manufacture and their use | Clariant GmbH (DE) | 1998-03-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260014282-A1 | METHODS OF FORMING RADIOPAQUE PEPTIDES FOR USE IN MEDICAL HYDROGELS | IAPP, NPPA, ARG1 | BHMT 2134/4885BHMT2 1671/4885SLC1A3 656/4885 |
| US-20230233592-A1 | PHARMACEUTICAL COMPOSITION FOR THE CHEMICAL INHIBITION OF TGS1 IN THE THERAPEUTIC TREATMENT OF TELOMEROPATHIES | POT1, SPTLC1, GAR1 | BHMT 805/4885BHMT2 1332/4885SLC1A3 4125/4885 |
| US-20250361531-A1 | MICROORGANISMS AND METHODS FOR PRODUCTION OF 4-HYDROXYBUTYRATE, 1,4-BUTANEDIOL AND RELATED COMPOUNDS | HSD17B10, HSD17B12, HADHB | BHMT 16/4885BHMT2 28/4885SLC1A3 1516/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.